SM-88 therapy in patients with advanced or metastatic pancreatic cancer

被引：1
|
作者：
Hoffman, Steve
Stega, Jeanetta
Zawisny, Patricia
Gostout, Zachary
Del Priore, Giuseppe
Loushin, Maria
Taylor, Ben R.
机构：
[1] Tyme Technol Inc, New York, NY USA
[2] Qual Res & Invent LLC, New York, NY USA
[3] Morehouse Sch Med, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
457
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II/III study of SM-88 in patients with metastatic pancreatic cancer
    Chung, Vincent
    Chawla, Sant P.
    Dong, Huan
    Kim, Semmie
    Korn, Ronald Lee
    Lim, Kian-Huat
    Noel, Marcus Smith
    Noonan, Anne M.
    Oberstein, Paul Eliezer
    Ocean, Allyson J.
    Pant, Shubham
    Picozzi, Vincent J.
    Philip, Philip Agop
    Rosemurgy, Alexander
    Tan, Benjamin R.
    Wang-Gillam, Andrea
    Wong, Steve
    Del Priore, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] SM-88 therapy in high risk poor prognosis pancreatic cancer (PDAC).
    Noel, Marcus Smith
    Wang-Gillam, Andrea
    Ocean, Allyson J.
    Chawla, Sant P.
    Chung, Vincent
    Del Priore, Giuseppe
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Phase II trial of SM-88 in patients with metastatic pancreatic cancer: Preliminary results of the first stage.
    Noel, Marcus Smith
    Wang-Gillam, Andrea
    Ocean, Allyson J.
    Chawla, Sant P.
    Del Priore, Giuseppe
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [4] SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)
    Nadi, M.
    Wang-Gillarn, A.
    Ocean, A.
    Chawla, S.
    Chung, V.
    DelPriore, G.
    Picozzi, V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] CTC-based efficacy of SM-88 correlates with overall survival in advanced pancreatic cancer
    Noel, Marcus Smith
    Wang-Gillam, Andrea
    Ocean, Allyson J.
    Chawla, Sant
    Chung, Vincent
    Korn, Ron
    Del Priore, Giuseppe
    Picozzi, Vincent J.
    CANCER RESEARCH, 2019, 79 (24)
  • [6] SM-88 in advanced cancers of the pancreas (SMACP).
    Noel, Marcus Smith
    Ocean, Allyson J.
    Sokol, Gerald H.
    Hoffman, Steve
    Del Priore, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer
    Benjamin A. Gartrell
    Mack Roach
    Avi Retter
    Gerald H. Sokol
    Giuseppe Del Priore
    Howard I. Scher
    Investigational New Drugs, 2021, 39 : 499 - 508
  • [8] SM-88 efficacy and safety in metastatic breast cancers.
    Zhu, Xinhua
    Noel, Marcus Smith
    Zawisny, Patricia
    Gostout, Zachary
    Decorato, Douglas
    Sokol, Gerald H.
    Loushin, Maria
    Del Priore, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond
    Noel, Marcus S.
    Kim, Semmie
    Hartley, Marion L.
    Wong, Steve
    Picozzi, Vincent J.
    Staszewski, Harry
    Kim, Dae Won
    Van Tornout, Jan M.
    Philip, Philip Agop
    Chung, Vincent
    Ocean, Allyson J.
    Wang-Gillam, Andrea
    CANCER MEDICINE, 2022, 11 (22): : 4169 - 4181
  • [10] Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer
    Gartrell, Benjamin A.
    Roach, Mack, III
    Retter, Avi
    Sokol, Gerald H.
    Del Priore, Giuseppe
    Scher, Howard I.
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (02) : 499 - 508
12345